$SIBN

SIBN Q2'26 Earnings: EPS estimate is (0.15) USD

Si-Bone, Inc. (SIBN) is scheduled to report Q2 2026 earnings on Aug. 3 after market close, with results expected at 4:09 PM ET. The consensus outlook cited for the quarter includes revenue of $55.34 million and EPS of -$0.15 (USD).

Original reporting
Published Jul 31, 2026, 11:00 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 31, 2026, 9:11 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
SIBN Q2'26 Earnings: EPS estimate is (0.15) USD — source image
Decision brief

The 30-second read

$SIBNNeutralMed
01

Why it matters

Traders can use the provided consensus numbers to frame expectations and plan around after-hours volatility on Aug 03.

02

Market read

Event-driven setup for an Aug 03 after-hours earnings print, with consensus expectations of $55.34M revenue and -$0.15 EPS.

03

What to watch

The article does not include guidance, margins, cash burn, or backlog details, which often dominate biotech/medtech earnings reactions beyond the headline EPS and revenue.

Relevance 6/10Novelty 5/10Timing: Aug 03 after the market close earnings release (4:09 PM ET disclosure time).

Background

The piece is an earnings preview for SIBN’s Q2'26 results, including consensus revenue and EPS and the after-hours release time.

Company-level read

Ticker impact

$SIBNNeutralMedium confidence
Context

SIBN is scheduled to announce Q2'26 results Aug 03 after the close, with consensus revenue of $55.34M and EPS of -$0.15.

Expected impact

Moderate two-sided volatility around the Aug 03 after-hours earnings release, driven by the gap versus the -$0.15 EPS and $55.34M revenue expectations.

Evidence & confidence

The article provides only consensus estimates and timing, not actual results or new guidance. That typically increases event-driven volatility but offers limited directional edge without additional qualitative drivers.

Market effects

Limited sector read-through because the article only provides company-specific consensus figures and release timing.

Primarily US small/mid-cap event risk; no cross-market policy or macro linkage is stated.

No global supply chain, regulatory, or geopolitical elements are mentioned.

Counterpoint

If the market already priced in the consensus EPS and revenue, the stock reaction could be muted unless management commentary materially changes expectations.

Key entities

  • SIBN

    SI-BONE, Inc., scheduled to report Q2'26 results on Aug 03 after the close.

Related articles

$SIBNHigh

SI-BONE, Inc. (SIBN): Results of Operations and Financial Condition

SI-BONE, Inc. (SIBN) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 exhibit991_q226earningsrel.htm EX-99.1 Document Exhibit 99.1 SI-BONE, Inc. Reports Financial Results for the Second Quarter 2026 and Raises 2026 Guidance Delivered ~15% WW revenue growth and ~178% increase in adjusted EBITDA ~19% increase in U.S. physician base Second Q

$HMNMed

Horace Mann Educators Q2 Earnings Call Highlights

Horace Mann (NYSE:HMN) reported Q2 call highlights. Management said auto frequency and severity trends were favorable and liability losses mid-single digits. It cut its full-year catastrophe-loss assumption to about $75M from $90M, while lowering total net investment income outlook to $465M-$475M. Revenue rose 8% YoY; life sales +20%.

$MURMedAI 8/10

Murphy Oil Sees Sharp Profit Increase

Murphy Oil Corp reported Q2 2026 adjusted net income of $225.8 million, nearly six times Q2 2025, as higher oil prices offset lower production and weaker gas. Adjusted EPS was $1.55 vs $1.51 consensus. Revenue rose to $926.3 million. Murphy kept its $0.35 dividend and raised 2026 capex midpoint to $1.55 billion.

$GSBDMed

Goldman Sachs BDC Q2 Earnings Call Highlights

Goldman Sachs BDC (NYSE:GSBD) reported no incentive fee in Q2, citing its three-year total-return lookback provision. NAV was $12.06/share at June 30 vs $12.17 in Q1. The board declared a Q3 base dividend of $0.32/share plus $0.03 supplemental. Investments were $3.2B fair value, non-accrual 2.9%, and net debt-to-equity 1.35x.

$HBBMed

Hamilton Beach Brands Q2 Earnings Call Highlights

Hamilton Beach Brands (HBB) reported Q2 gross margin of 26.1% excluding tariff-related benefits, and said it expects 2026 revenue growth in the mid-single-digit range. Management forecast full-year gross margin to improve modestly and operating profit to decline by a high-single-digit percentage. Operating cash flow is expected at $35M to $45M. HBB ended with net cash of $51.5M.